These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6929890)

  • 1. Soluble tumor-associated antigen of human intracranial glioma.
    Lin SM; Lee CS; Chuang CY; Hung CC
    Taiwan Yi Xue Hui Za Zhi; 1980 Feb; 79(2):109-14. PubMed ID: 6929890
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressor cell activity triggered by tumor associated antigen in patients with intracranial glioma.
    Lin SM; Hung CC
    Taiwan Yi Xue Hui Za Zhi; 1986 Jan; 85(1):8-18. PubMed ID: 2940327
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human intracranial glioma.
    Lin SM; Lee CS; Chuang CY; Hung CC
    Taiwan Yi Xue Hui Za Zhi; 1979 Feb; 78(2):111-9. PubMed ID: 286750
    [No Abstract]   [Full Text] [Related]  

  • 4. Human intracranial tumors: effect of autologous serum addition on leucocyte migration inhibition.
    Böker DK
    Acta Neurochir (Wien); 1982; 65(3-4):227-37. PubMed ID: 7180599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on cellular immunity of brain tumors; glial carcinofetal antigens and serum blocking factors in gliomas (author's transl)].
    Oda Y
    Nihon Geka Hokan; 1974 Mar; 43(2):111-23. PubMed ID: 4472615
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in the cellular immune response of patients with cerebral glioma, benign intracranial tumour, and spontaneous subarachnoid haemorrhage measured in vitro by the leucocyte migration inhibition test.
    Bean JR; Darling JL; Hoyle NR; Arigbabu SO; Thomas DG
    Neurol Res; 1983; 5(1):61-75. PubMed ID: 6140656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular immunity in human brain tumours (author's transl)].
    Böker DK
    Neurochirurgia (Stuttg); 1980 Nov; 23(6):229-34. PubMed ID: 7442895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.
    Ueda R; Yoshida K; Kawase T; Kawakami Y; Toda M
    Int J Cancer; 2007 Apr; 120(8):1704-11. PubMed ID: 17230535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunogenic antigens increase classification accuracy in meningioma to 93.84%.
    Ludwig N; Keller A; Heisel S; Leidinger P; Rheinheimer S; Andres C; Stephan B; Steudel WI; Donauer E; Graf N; Burgeth B; Weickert J; Lenhof HP; Meese E
    Int J Cancer; 2011 Mar; 128(6):1493-501. PubMed ID: 20506373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of soluble hepatocellular carcinoma extracts.
    Lee CS; Chuang CY; Lin FY; Lin TY
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Sep; 12(3):81-5. PubMed ID: 232674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human meningioma antigens.
    Winters WD; Rich JR
    Int J Cancer; 1975 May; 15(5):815-22. PubMed ID: 806546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients.
    Woosley RE; Mahaley MS; Mahaley JL; Miller GM; Brooks WH
    J Neurosurg; 1977 Dec; 47(6):871-85. PubMed ID: 200722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of basic encephalitogenic protein and some peptides derived from it on the migration in agarose gel of leukocytes from patients with multiple sclerosis, other neurological diseases, or carcinoma.
    Bergstrand H; Källén B; Nilsson O
    Acta Neurol Scand; 1974; 50(2):227-47. PubMed ID: 4134200
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro demonstration of cell-mediated immunity to human brain tumors.
    Levy NL; Mahaley MS; Day ED
    Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor markers of the central nervous system.
    Birkmayer GD
    Cancer Detect Prev; 1981; 4(1-4):231-8. PubMed ID: 7349780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a soluble tumor-associated antigen from human renal cell carcinoma by gradient acrylamide gel electrophoresis.
    Wright GL; Schellhammer PF; Faulconer RL
    Cancer Res; 1977 Nov; 37(11):4228-32. PubMed ID: 911404
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor markers: malignin and related recognins associated with malignancy rather than with cell type.
    Bogoch S; Bogoch ES
    Prog Clin Biol Res; 1980; 39():407-24. PubMed ID: 7403189
    [No Abstract]   [Full Text] [Related]  

  • 19. Serological analysis of tumor antigens in malignant glioma patients.
    Yoshida S; Tanaka R; Ono K
    Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of the natural killer cells in the peripheral blood of patients with brain tumors].
    Lisianyĭ NI; Markova OV; Zhmareva EN
    Eksp Onkol; 1988; 10(3):57-9. PubMed ID: 3409835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.